RSC Advances
Page 4 of 4
DOI: 10.1039/C5RA20258B
captured by a nucleophilic trifluoethanol. It is worthy to note that, 40 aSchool of Pharmaceutical Science and Technology, Tianjin University,
when the para position of ring B was a methoxy group, substrate
1r was converted to the spiro 2r in 62% yield under standard
conditions (Scheme 1, eq 2). It is evident that the presence of the
methoxy group facilities the ipso attack of the
Tianjin 300072, China. E-mail: duyunfeier@tju.edu.cn;
Fax: +86-22-27404031; Tel: +86-22-27404031
bCollaborative Innovation Center of Chemical Science and Engineering
(Tianjin), Tianjin 300072, China. E-mail: duyunfeier@tju.edu.cn;
45 Fax: +86-22-27404031; Tel: +86-22-27404031
5
Notes and references
(1) K. Nagarajan, J. David, Y. S. Kulkarni, S. B. Hendi, S. J. Shenoy and
50
55
P. Upadhyaya, Eur. J. Med. Chem., 1986, 21, 21.
(2) M. Binaschi, A. Boldetti, M. Gianni, C. A. Maggi, M. Gensini, M.
Bigioni, M. Parlani, A. Giolitti, M. Fratelli, C. Valli, M. Terao and
Garattini, E. Med. Chem. Lett., 2010, 1, 411.
(3) J. M. Klunder, K. D. Hargrave, M. A. West, E. Cullen, K. Pal, M. L.
Behnke, S. R. Kapadia, D. W. McNeil, J. C. Wu, G. C. Chow and J.
Adams, J. Med. Chem., 1992, 35, 1887.
Scheme 1 Other models that failed to afford dibenzoxazepinone
(4) J.ꢀF. F. Liegeois, F. A. Rogistert, J. Bruhwyler, J. Damas, T. P.
Nguyen, M.ꢀO. Inarejos, E. M. G. Chleide, M. G. A. Mercier and J. E.
Delarget, J. Med. Chem., 1994, 37, 519.
60 (5) F. Hollosy, K. Valko, A. Hersey, S. Nunhuck, G. Keri and C. Bevan, J.
Med. Chem., 2006, 49, 6958.
(6) Y. Liao, B. J. Venhuis, N. Rodenhuis, W. Timmerman and H.
Wikstrom, J. Med. Chem., 1999, 42, 2235.
(7) Y. Nagai, A. Irie, H. Nakamura, K. Hino, H. Uno and H. Nishimura, J.
O
O
Pd/C, H2, AcOH
70 oC, 24 h
76%
N
NH
8a
OMe
O
O
2a
Scheme 2 The removal of methoxy group in 2a
65
Med. Chem., 1982, 25, 1065.
10
(8) R. A. Bunce and J. E. Schammerhorn, J. Heterocycl. Chem., 2006, 43,
nitrenium ion onto the ring B. The Nꢀunsubstitued products are
also potential building block for the synthesis of important
pharmaceutical agents with biological activities.1ꢀ6 As illustrated
in Scheme 2, the Nꢀmethoxy dibenzoxazepinone could be readily
15 converted to Nꢀunsubstitued dibenzoxazepinone, through
palladium catalyzed hydrogenation reaction,16 which allows for
the further derivatization of the free NH moiety for synthesizing
antidepressant dibenzoxazepinone and HDAC inhibitor B2.
1031.
(9) Y. Liu, C. Chu, A. Huang, C. Zhan, Y. Ma and C. Ma, Comb. Sci.,
2011, 13, 547.
70 (10) S. Lu and H. Alper, J. Am. Chem. Soc., 2005, 127, 14776.
(11) K. Najarajan, Indian J. Chem., 1974, 12, 252.
(12) For selected examples, see: (a) Y. Kikugawa and M. Kawase, Chem.
Lett., 1990, 4, 581. (b) A. G. Romero, W. H. Darlington, E. J.
Jacobsen and J. W. Mickelson, Tetrahedron. Lett., 1996, 37, 2361. (c)
75
80
85
M. T. Herrero, I. Tellitu, E. Domínguez, S. Hernández, I. Moreno
and R. SanMartin, Tetrahedron, 2002, 58, 8581. (d) E. Miyazawa, T.
Sakamoto and Y. Kikugawa, Heterocycles, 2003, 59, 149. (e) S.
Serna, I. Tellitu, E. Domínguez, I. Moreno and R. SanMartin,
Tetrahedron, 2004, 60, 6533. (f) A. Correa, I. Tellitu, E. Domínguez,
I. Moreno and R. SanMartin, J. Org. Chem., 2005, 70, 2256. (g) K.
Inoue, Y. Ishikawa and S. Nishiyama, Org. Lett., 2010, 12, 436. (h)
D. J. Wardrop and E. G. Bowen, Org. Lett., 2011, 13, 2376. (i) D. J.
Wardrop, M. V. Yermolina and E. G. Bowen, Synthesis, 2012, 44,
1199. (j) X. Li, L. Yang, X. Zhang, D. Negrerie, Y. Du and K. Zhao,
J. Org. Chem., 2014, 79, 955.
20 Conclusions
In summary, we have developed a novel method for the
construction
(aryloxy)benzamides
of
the
through
biologically
an
interesting
iodine(III)ꢀmediated
2ꢀ
25 intermolecular CꢀN bond formation. Advantages of the method
include the readily availability of the starting materials, the mild
reaction conditions, and the transitionꢀ metalꢀfree feature.
Moreover, the transformation tolerates a wide range of functional
groups, and the Nꢀmethoxy group in the final products can be
30 readily removed and allows for further derivatization.
(13) (a) T. Akbarzadeh, S. A. Tabatabai, M. J. Khoshnoud, B. Shafaghic
and A. Shafieea, Bioorg. Med. Chem., 2003, 11, 769. (b) M. J.
Assarzadeh, A. Almasirad, A. Shafiee, M. N. Koopaei and M.
Abdollahi, Med. Chem. Res., 2014, 23, 948.
90 (14) (a) R. Giri, J. R. Goodell, C. Xing, A. Benoit, H. Kaur, H. Hiasa and
D. M. Ferguson, Bioorg. Med. Chem., 2010, 18, 1456. (b) R.
Arundhathi, D. Damodara, A. P. R. Likhar, M. L. Kantam, P.
Saravanan, T. Magdaleno and S. H. Kwonc, Adv. Synth. Catal., 2011,
353, 1591.
95 (15) M. O. Anderson, M. Jamie, S. John and R. K. Guy, Synlett 2004, 13,
2391.
(16) A. M. Birch, P. W. Kenny, N. G. Oikonomakos, L. Otterbein, P.
Schofield, P. R. O. Whittaamore and D. P. Whalley, Bioorg. Med.
Chem. Lett., 2007, 17, 394.
Acknowledgements
We acknowledge the National Science Foundation of China
35 (#21472136) and the National Basic Research Project
(2015CB856500) for financial support.
Notes and references
100
4
|
Journal Name, [year], [vol], 00–00
This journal is © The Royal Society of Chemistry [year]